Global Market of Monoclonal Antibodies: Sales, Prices, Demand

Bio-pharmaceutics is one of the most science-intensive industries. Annually a lot of money is spent on applied research aimed at development and commercialization of new medications. Many pharmaceutical companies try to have in their product line or pipeline drugs on the basis of monoclonal antibodi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	D. A. Uvarov
Formato:	article
Lenguaje:	RU
Publicado:	Plekhanov Russian University of Economics 2021
Materias:	bio-pharmaceutics pharmaceutical market monoclonal antibodies bio-analogues bio-similars sales biotechnologies target therapy bigpharma industries innovation production Economics as a science HB71-74
Acceso en línea:	https://doaj.org/article/1a41fb7c978246e0837d4972590966d0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1a41fb7c978246e0837d4972590966d0
record_format	dspace
spelling	oai:doaj.org-article:1a41fb7c978246e0837d4972590966d02021-11-15T05:20:50ZGlobal Market of Monoclonal Antibodies: Sales, Prices, Demand2413-28292587-925110.21686/2413-2829-2021-2-64-76https://doaj.org/article/1a41fb7c978246e0837d4972590966d02021-04-01T00:00:00Zhttps://vest.rea.ru/jour/article/view/1049https://doaj.org/toc/2413-2829https://doaj.org/toc/2587-9251Bio-pharmaceutics is one of the most science-intensive industries. Annually a lot of money is spent on applied research aimed at development and commercialization of new medications. Many pharmaceutical companies try to have in their product line or pipeline drugs on the basis of monoclonal antibodies, i.e. a class of biotechnological preparations that are used to combat oncologic and autoimmune diseases and are based on target therapy principle. Because of the high interest in bio-pharmaceutical industry on the part of businessmen, state and science any advanced data dealing with the situation inside the market can be useful for shaping the adequate picture of the present day condition and for making managerial decisions on state and private level. The article provides information about global sales of preparations based on monoclonal antibodies. Apart from sales in terms of money the author calculates the natural volume of products being sold based on price analysis of products. The article gives a list of preparations registered on EU and US markets rated by their sales. By analyzing preparation prices corrected to dosage it was possible to find the most expensive and the cheapest medications in their class. Information concerning the natural volume of drug being sold can help understand the scale of preparation production.D. A. UvarovPlekhanov Russian University of Economicsarticlebio-pharmaceuticspharmaceutical marketmonoclonal antibodiesbio-analoguesbio-similarssalesbiotechnologiestarget therapybigpharmaindustriesinnovation productionEconomics as a scienceHB71-74RUВестник Российского экономического университета имени Г. В. Плеханова, Vol 18, Iss 2, Pp 64-76 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	bio-pharmaceutics pharmaceutical market monoclonal antibodies bio-analogues bio-similars sales biotechnologies target therapy bigpharma industries innovation production Economics as a science HB71-74
spellingShingle	bio-pharmaceutics pharmaceutical market monoclonal antibodies bio-analogues bio-similars sales biotechnologies target therapy bigpharma industries innovation production Economics as a science HB71-74 D. A. Uvarov Global Market of Monoclonal Antibodies: Sales, Prices, Demand
description	Bio-pharmaceutics is one of the most science-intensive industries. Annually a lot of money is spent on applied research aimed at development and commercialization of new medications. Many pharmaceutical companies try to have in their product line or pipeline drugs on the basis of monoclonal antibodies, i.e. a class of biotechnological preparations that are used to combat oncologic and autoimmune diseases and are based on target therapy principle. Because of the high interest in bio-pharmaceutical industry on the part of businessmen, state and science any advanced data dealing with the situation inside the market can be useful for shaping the adequate picture of the present day condition and for making managerial decisions on state and private level. The article provides information about global sales of preparations based on monoclonal antibodies. Apart from sales in terms of money the author calculates the natural volume of products being sold based on price analysis of products. The article gives a list of preparations registered on EU and US markets rated by their sales. By analyzing preparation prices corrected to dosage it was possible to find the most expensive and the cheapest medications in their class. Information concerning the natural volume of drug being sold can help understand the scale of preparation production.
format	article
author	D. A. Uvarov
author_facet	D. A. Uvarov
author_sort	D. A. Uvarov
title	Global Market of Monoclonal Antibodies: Sales, Prices, Demand
title_short	Global Market of Monoclonal Antibodies: Sales, Prices, Demand
title_full	Global Market of Monoclonal Antibodies: Sales, Prices, Demand
title_fullStr	Global Market of Monoclonal Antibodies: Sales, Prices, Demand
title_full_unstemmed	Global Market of Monoclonal Antibodies: Sales, Prices, Demand
title_sort	global market of monoclonal antibodies: sales, prices, demand
publisher	Plekhanov Russian University of Economics
publishDate	2021
url	https://doaj.org/article/1a41fb7c978246e0837d4972590966d0
work_keys_str_mv	AT dauvarov globalmarketofmonoclonalantibodiessalespricesdemand
_version_	1718428601706086400

Global Market of Monoclonal Antibodies: Sales, Prices, Demand

Ejemplares similares